Progress and Prospects in Translating Nanobiotechnology in Medical Theranostics

Author(s): Amna Batool, Farid Menaa*, Bushra Uzair, Barkat Ali Khan, Bouzid Menaa

Journal Name: Current Nanoscience

Volume 16 , Issue 5 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

The pace at which nanotheranostic technology for human disease is evolving has accelerated exponentially over the past five years. Nanotechnology is committed to utilizing the intrinsic properties of materials and structures at submicroscopic-scale measures. Indeed, there is generally a profound influence of reducing physical dimensions of particulates and devices on their physico-chemical characteristics, biological properties, and performance. The exploration of nature’s components to work effectively as nanoscaffolds or nanodevices represents a tremendous and growing interest in medicine for various applications (e.g., biosensing, tunable control and targeted drug release, tissue engineering). Several nanotheranostic approaches (i.e., diagnostic plus therapeutic using nanoscale) conferring unique features are constantly progressing and overcoming all the limitations of conventional medicines including specificity, efficacy, solubility, sensitivity, biodegradability, biocompatibility, stability, interactions at subcellular levels.

This review introduces two major aspects of nanotechnology as an innovative and challenging theranostic strategy or solution: (i) the most intriguing (bare and functionalized) nanomaterials with their respective advantages and drawbacks; (ii) the current and promising multifunctional “smart” nanodevices.

Keywords: Nanotechnology, nanomedicine, nanotheranostics, nanoplatforms, nanodevices, nanomaterials, nanostructures, nanosystems, translational medicine, innovation.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 5
Year: 2020
Page: [685 - 707]
Pages: 23
DOI: 10.2174/1573413715666191126093258
Price: $65

Article Metrics

PDF: 6